West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 355,900 | 368,900 | 346,800 | 342,700 | 341,800 |
| Cost of Goods | 246,000 | 247,100 | 240,400 | 236,100 | 236,300 |
| Gross Profit | 109,900 | 121,800 | 106,400 | 106,600 | 105,500 |
| Operating Expenses | 65,900 | 67,800 | 67,500 | 69,800 | 66,100 |
| Operating Income | 44,000 | 54,100 | 39,300 | 36,900 | 39,700 |
| Interest Expense | 4,500 | 4,200 | 4,000 | 3,900 | 4,400 |
| Other Income | 3,200 | 1,700 | 1,600 | 1,300 | 2,100 |
| Pre-tax Income | 42,700 | 51,600 | 36,900 | 34,300 | 37,400 |
| Income Tax | 11,700 | 14,000 | 9,800 | 10,700 | 10,600 |
| Net Income Continuous | 31,000 | 37,600 | 27,100 | 23,600 | 26,800 |
| Net Income | $31,000 | $37,600 | $27,100 | $23,600 | $26,800 |
| EPS Basic Total Ops | 0.44 | 0.53 | 0.38 | 0.33 | 0.38 |
| EPS Basic Continuous Ops | 0.44 | 0.53 | 0.38 | 0.34 | 0.38 |
| EPS Diluted Total Ops | 0.43 | 0.52 | 0.38 | 0.32 | 0.37 |
| EPS Diluted Continuous Ops | 0.43 | 0.52 | 0.37 | 0.32 | 0.38 |
| EBITDA(a) | $67,100 | $77,200 | $61,100 | $59,000 | $61,600 |